## **Trustees’ Annual Report for the period** ## **From: 01/10/2024 (Period start date) To: 30/09/2025 (Period end date)** ## **Charity name: RangerLab** ## **Charity registration number: 1198948** ## **Objectives and Activities** ||SORP reference|| |---|---|---| |Summary of the purposes of
the charity as set out in its
governing document|Para 1.17|For the public benefit, to relieve the needs
of those individuals working as wildlife
rangers in any part of the world who lack
the means to meet basic personal welfare
or working standards in particular but not
exclusively through the provision of grants
and the provision of goods directly related
to improving their personal and working
welfare such as socks, boots, uniforms and
dental and hygiene products. For the
purposes of this clause, ‘wildlife ranger’ is
defined as ‘the person involved in the
practical protection and preservation of all
aspects of wild areas, historical and cultural
sites.| |Summary of the main
activities in relation to those
purposes for the public
benefit, in particular, the
activities, projects or
services identified in the
accounts.|Para 1.17 and
1.19|See response in Achievements and
Performance.| |Statement confirming
whether the trustees have
had regard to the guidance
issued by the Charity
Commission on public
benefit|Para 1.18|RangerLab Trustees have had regard to
guidance issued by the Charity
Commission on public benefit.| ## **Achievements and Performance** ||SORP reference|| |---|---|---| |Summary of the main
achievements of the charity,
identifying the difference the
charity’s work has made to
the circumstances of its
beneficiaries and any wider
benefits to society as a
whole.|Para 1.20|The Charity was, in effect, in stasis for the
year, whilst it made relevant plans to
wind-down, including settling existing
assets and liabilities.
The Trustees have had regard to the
relevant guidelines on grant-making.| It was decided that the organisation made a considered decision, rather than proceeding hastily to select a suitable onward benefactor for our remaining funds. The organisation has now made adequate plans to wind-down the organisation in due course, including making a transfer of the remaining funds to a UK registered charity continuing to deliver a similar benefit to that which RangerLab set out to achieve. We will communicate more details on this in our final report. We wish to put on record how immensely grateful we are to all those who supported us on our journey. ## **Financial Review** |Review of the charity’s
financial position at the end
of the period|Para 1.21|The charity’s financial position at the end of
the period was stable, amounting to £5,287.
No liabilities are outstanding.| |---|---|---| |
Statement explaining the
policy for holding reserves
stating why they are held|Para 1.22|
Reserves were held in the period to protect
the financial robustness of the charity from
any fundraising risks.| |Amount of reserves held|Para 1.22|See above.| |Reasons for holding zero
reserves|Para 1.22|N/A| |Details of fund materially in
deficit|Para 1.24|N/A| |Explanation of any
uncertainties about the
charity continuing as a going
concern|Para 1.23|The organisation will take necessary steps
to wind down, as stated in the “_Summary of_
_the main achievements_” tab, above. The
organisation has no outstanding liabilities.| ## **Structure, Governance and Management** |Description of charity’s
trusts:||| |---|---|---| |Type of governing document
(trust deed, royal charter)|Para 1.25|CIO Constitution Foundation Model| |How is the charity
constituted?
(e.g unincorporated
association, CIO)|Para 1.25|CIO| |
Trustee selection methods
including details of any
constitutional provisions e.g.
election to post or name of
any person or body entitled
to appoint one or more
trustees|Para 1.25|New trustees are appointed by the existing
trustees of the charity.| ## **Additional information (optional)** You may choose to include further statements where relevant about: |Policies and procedures
adopted for the induction
and training of trustees|Para 1.51|| |---|---|---| |The charity’s organisational
structure and any wider
network with which the
charity works|Para 1.51|RangerLab Trading Ltd, company number
14300749 (“the Trading Co”), was
incorporated as a company limited by
shares on 16 August 2022. RangerLab
Studios CIC, company number 14973014
(“the CIC”) was incorporated as a
community interest company limited by
guarantee on 30 June 2023.
These are both in the process of winding
down, which will effective in the next
financial period.| |Relationship with any
related parties|Para 1.51|
Trading subsidiaries designed principally to
generate income for the charity.| |Other||| ## **Reference and Administrative details** |Charity name|RangerLab| |---|---| |
Other name the charity uses|| |Registered charity number|1198948| |Charity’s principal address|23 Little Orchard Way
Shalford
Guildford
Surrey
GU4 8JY| ## **Names of the charity trustees who manage the charity** |1
2
3
4|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**
**year**
**Name of person (or**
**body) entitled to appoint**
**trustee (if any)**| |---|---|---|---| ||Douglas Flynn||| ||Stephen Pomphrey||| ||Michael Geldard
OBE||| ||Crispin
Lyden-Cowan||| ## **Name of chief executive or names of senior staff members** Lewis Bedford – Honorary Executive Director ## **Declarations** ## **The trustees declare that they have approved the trustees’ report above.** ## **Signed on behalf of the charity’s trustees** |||| |---|---|---| ||**Signature(s)**Stephen Pomphrey
**Full name(s)**Stephen Pomphrey
**osition (eg Secretary,**
**Chair, etc)**
Trustee
**Date**28/07/2026|| |||| |||| |**P**||| |||| **Charity Name No (if any) RangerLab 1198948 Receipts and payments accounts** **No (if any) 1198948 CC16a** **For the period** Period start date Period end date **To from** 1-Oct-24 30-Sep-25 ## **Section A Receipts and payments** |||||**Unrestricted**
**funds**|||||**Restricted funds**|**Restricted funds**|**Restricted funds**|**Restricted funds**||||**Endowment**
**funds**|**Endowment**
**funds**|||||||**Total funds**||||||**Last year**|||| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |||||**to the nearest**|**£**|||||**to the nearest £**||||||**to the nearest**|**£**|||||||**to the nearest £**||||||**to the nearest £**|||| |**A1 Receipts**|||||||||||||||||||||||||||||||||| |Voluntary receipts|||**-**|**356**||**-**|||**-**|**-**||**-**|||**-**||**-**|||**-**|||**-**|**356**||**-**|||**-**|**14,329**||**-**|| |Grants|||**-**||**-**|**-**|||||||||**-**||**-**|||**-**|||**-**|**-**||**-**|||**-**|**9,216**||**-**|| |Events|||**-**||**-**|**-**|||**-**|**-**||**-**|||**-**||**-**|||**-**|||**-**|**-**||**-**|||||||| |Goods in kind|||**-**||**-**|**-**|||**-**|**-**||**-**|||**-**||**-**|||**-**|||**-**|**-**||**-**|||||||| |Payment of recoverable loans|||**-**|**4,004**||**-**|||**-**|**-**||**-**|||**-**||**-**|||**-**|||**-**|**4,004**||**-**|||**-**|**-**||**-**|| ||||**-**||**-**|**-**|||**-**|**-**||**-**|||**-**||**-**|||**-**|||**-**|**-**||**-**|||**-**|**-**||**-**|| ||||**-**||**-**|**-**|||**-**|**-**||**-**|||**-**||**-**|||**-**|||**-**|**-**||**-**|||**-**|**-**||**-**|| ||||**-**||**-**|**-**|||**-**|**-**||**-**|||**-**||**-**|||**-**|||**-**|**-**||**-**|||**-**|**-**||**-**|| |**_Sub total_**
_(Gross income for AR)_|||**-**|**4,360**
**-**|||||**-**|**-**|**-**||||**-**||**-**||**-**||||**-**|**4,360**|**-**||||**-**|**23,545**|**-**||| ||||||||||||||||||||||||||||||||||| |**A2 Asset and investment**|**sales,**||||||||||||||||||||||||||||||||| |**(see table).**|||||||||||||||||||||||||||||||||| ||||**-**||**-**|**-**|||**-**|**-**||**-**|||**-**|||**-**||**-**|||**-**|**-**||**-**|||||||| ||||**-**||**-**|**-**|||**-**|**-**||**-**|||**-**|||**-**||**-**|||**-**|**-**||**-**|||**-**|**-**||**-**|| ||**_Sub total_**||**-**||**-**
**-**||||**-**|**-**|**-**||||**-**|||**-**|**-**||||**-**|**-**|**-**||||**-**|**-**|**-**||| |**A2 Asset and investment sales,**
**(see table).**|||||||||||||||||||||||||||||||||| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |||**-**||**-**|**-**|||**-**||**-**|||**-**|||**-**||**-**|||**-**|||**-**|**-**||**-**||||||| |||**-**||**-**|**-**|||**-**||**-**|||**-**|||**-**||**-**|||**-**|||**-**|**-**||**-**|||**-**|**-**|**-**|| |**_Sub total_**||**-**||**-**
**-**||||**-**||**-**||**-**||||**-**||**-**||**-**||||**-**|**-**|**-**||||**-**|**-**
**-**||| ||||||||||||||||||||||||||||||||||| |**_Total receipts_**||**-**||**4,360**
**-**||||**-**||**-**|**-**|||||**-**||**-**|**-**|||||**-**|**4,360**|**-**||||**-**|**23,545**
**-**||| |**A3 Payments**|||||||||||||||||||||||||||||||||| |Cost of charitable activities||**-**||**-**|**-**|||**-**|**-**||||**-**|||**-**|**-**||||**-**|||**-**|**-**||**-**|||**-**|**7,000**|**-**|| |Settlement of final liabilities||**-**|**£**|**4,455.00**|**-**|||**-**|**-**||||**-**|||**-**|**-**||||**-**|||**-**|**4,455**||**-**|||**-**|**5,498**|**-**|| |Administrative costs||**-**|**£**|**1,840.00**|**-**|||**-**|**-**||||**-**|||**-**|**-**||||**-**|||**-**|**1,840**||**-**|||**-**|**691**|**-**|| |||**-**||**-**|**-**|||**-**|**-**||||**-**|||**-**|**-**||||**-**|||**-**|**-**||**-**|||**-**|**-**|**-**|| CCXX R1 accounts (SS) 28/07/2026 1 |||**-**|**-**|**-**|||**-**|**-**
**-**|**-**
**-**|||**-**|**-**
**-**|**-**
**-**|||**-**|**-**
**-**|**-**
**-**|||**-**|**-**
**-**|**-**
**-**|| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |||**-**|**-**|**-**|||**-**|**-**
**-**||||**-**|**-**
**-**||||**-**|**-**
**-**||||**-**|**-**
**-**||| |||**-**|**-**|**-**|||**-**|**-**
**-**||||**-**|**-**
**-**||||**-**|**-**
**-**||||**-**|**-**
**-**||| |||**-**|**-**|**-**|||**-**|**-**
**-**||||**-**|**-**
**-**||||**-**|**-**
**-**||||**-**|**-**
**-**||| |||**-**|**-**|**-**|||**-**|**-**
**-**||||**-**|**-**
**-**||||**-**|**-**
**-**||||**-**|**-**
**-**||| |**_Sub total_**||**-**|**-**
**6,295**||||**-**|**-**
**-**||||**-**|**-**
**-**||||**-**|**6,295**|**-**|||**-**|**13,189**|**-**|| ||||||||||||||||||||||||||| |**_Sub total_**|**_Sub total_**||**-**|**-**
**6,295**|||**-**|**-**|**-**|**-**|**-**|||**-**|**-**|**-**|**-**|**-**|||**-**|**6,295**|**6,295**|**-**|**-**|||**-**|**13,189**|**13,189**|**-**|| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |||||||||||||||||||||||||||||||||| |**A4 Asset and investment**||||||||||||||||||||||||||||||||| |**purchases, (see table)**||||||||||||||||||||||||||||||||| |Other cash items from financing activities
(Loan)|||**-**|**-**
**-**|||**-**||**-**
**-**|||||**-**||**-**
**-**|||||**-**|**-**
**-**||||||**-**|**-**
**3,134**|||| ||||**-**|**-**
**-**|||**-**||**-**
**-**|||||**-**||**-**
**-**|||||**-**|**-**
**-**||||||||||| |**_Sub total_**|||**-**|**-**
**-**|||**-**||**-**||**-**|||**-**||**-**||**-**|||**-**|**-**||**-**||||**-**|**3,134**||**-**|| |||||||||||||||||||||||||||||||||| |**_Total payments_**|||**-**|**-**
**6,295**|||**-**||**-**|**-**||||**-**||**-**|**-**||||**-**|**6,295**||**-**||||**-**|**16,323**|**-**||| |||||||||||||||||||||||||||||||||| |**_Net of receipts/(payments)_**|||**-**|**-**
**1,935**|||**-**|**-**||**-**||||**-**|**-**||**-**||||**-**|**1,935**|**-**|||||**-**|**7,222**|**-**||| |**A5 Transfers between funds**|||**-**|**-**
**-**|||**-**|**-**
**-**||||||**-**|**-**
**-**||||||**-**|**-**
**-**||||||**-**|**-**
**-**|||| |**A6 Cash funds last year end**|||**-**|**-**
**7,222**|||**-**|**-**
**-**||||||**-**|**-**
**-**||||||**-**|**7,222**|||**-**|||**-**|**-**
**-**|||| |**_Cash funds this year end_**|||**-**|**-**
**5,287**|||**-**|**-**||**-**||||**-**|**-**||**-**||||**-**|**5,287**|**-**|||||**-**|**7,222**|**-**||| |||||||||||||||||||||||||||||||||| ## **Section B Statement of assets and liabilities at the end of the period** ||||||**Unrestricted**||||**Restricted funds**|**Restricted funds**|**Restricted funds**||||**Endowment**||| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| ||**Categories**|**Details**|||**funds**||||||||||**funds**||| ||||||**to nearest £**|||||**to nearest £**|||||**to nearest £**||| |**B1**|**Cash funds**|Community Direct Account|||**5,287.00**||||**-**|**-**
**-**||||**-**|**-**
**-**||| |||||**-**|**-**
**-**||||**-**|**-**
**-**||||**-**|**-**
**-**||| |||||**-**|**-**
**-**||||**-**|**-**
**-**||||**-**|**-**
**-**||| |||**_Total cash funds_**|||**5,287.00**||||**-**|**-**
**-**||||**-**|**-**
**-**||| |||(agree balances with receipts and payments|||||||||||||||| |||account(s))||OK|||||OK|||||OK|||| ||||||**Unrestricted**||||**Restricted funds**||||||**Endowment**||| ||||||**funds**||||||||||**funds**||| CCXX R2 accounts (SS) 28/07/2026 2 |**B2 Other monetary assets**
**B3 Investment assets**
**B4 Assets retained for the**
**charity’s own use**|**Details**|**to nearest £**|**to nearest £**|**to nearest £**| |---|---|---|---|---| ||||**-**
**-**
**-**|**-**
**-**
**-**| |||**-**
**-**
**-**|**-**
**-**
**-**|**-**
**-**
**-**| |||**-**
**-**
**-**|**-**
**-**
**-**|**-**
**-**
**-**| |||**-**
**-**
**-**|**-**
**-**
**-**|**-**
**-**
**-**| |||**-**
**-**
**-**|**-**
**-**
**-**|**-**
**-**
**-**| |||**-**
**-**
**-**|**-**
**-**
**-**|**-**
**-**
**-**| |||||**Current value**
**(optional)**| |||||**-**
**-**
**-**| |||||**-**
**-**
**-**| |||||**-**
**-**
**-**| |||||**-**
**-**
**-**| |||||**-**
**-**
**-**| |||||**Current value**
**(optional)**| ||||**-**
**-**
**-**|**-**
**-**
**-**| ||||**-**
**-**
**-**|**-**
**-**
**-**| ||||**-**
**-**
**-**|**-**
**-**
**-**| ||||**-**
**-**
**-**|**-**
**-**
**-**| ||||**-**
**-**
**-**|**-**
**-**
**-**| ||||**-**
**-**
**-**|**-**
**-**
**-**| ||||**-**
**-**
**-**|**-**
**-**
**-**| ||||**-**
**-**
**-**|**-**
**-**
**-**| ||||**-**
**-**
**-**|**-**
**-**
**-**| |||||| CCXX R3 accounts (SS) 28/07/2026 3 |**B5 Liabilities**
Signed by one or two trustees on behalf
of all the trustees|**Details**|**Details**|**Fund to which**
**liability relates**|**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**When due**
**(optional)**| |---|---|---|---|---|---|---| |||||||| |||||||| |||||||| |||||||| |||||||| |||||||| ||Signature||Print Name|||Date of approval| ||Stephen Pomphrey||Stephen Pomphrey|||28/07/2026| |||||||| CCXX R4 accounts (SS) 28/07/2026 4